ARCHIVES

FDA Continues Bureaucratic Delays Of Cancer INDs

This article is from The Cancer Letter archive.

Vol. 02 No. 05 | January 30, 1976

Download PDF Visit The Full Archive

Related Articles

Et2’s Referral Guidelines

July 23, 1993

Edelson To Step Down As Yale Center Director.

January 11, 2008

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

March 25, 2011

Mouse Strains Now Available From NCI

March 18, 1983

Nucynta ER Approved For Managing Chronic Pain In Adults

September 30, 2011

In Brief: FASEB Report On Diet and Cancer Mortality Available; Don Poppke AO of Nursing Center

March 6, 1987